EGFR and non-small cell lung carcinoma: In order to clarify the value of mutation-specific antibodies in the identification of EGFR mutation status, a meta-analysis was conducted to systematically and quantitatively evaluate the accuracy of the immunohistochemical method for EGFR mutation screening in NSCLC.